|
1
|
Meyers PA, Schwartz CL, Krailo M,
Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W,
Gebhardt M, Goorin AM, et al: Osteosarcoma: A randomized,
prospective trial of the addition of ifosfamide and/or muramyl
tripeptide to cisplatin, doxorubicin and high-dose methotrexate. J
Clin Oncol. 23:2004–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raymond AK, Ayala AG and Nuutila S:
Conventional osteosarcomaWorld Health Organization classification
of tumors: Pathology and genetics; tumors of soft tissue and bone.
Fletcher CDM, Unni KK and Mertens F: International Agency for
Research on Cancer; Lyon: pp. 24–70. 2002
|
|
3
|
Uni KK and Inwards CY:
OsteosarcomaDahlin's bone tumors. 6th edition. Uni KK and Inwards
CY: Wolters Kluwer, Lippincott Williams and Wilkins; Philadelphia:
pp. 122–157. 2010
|
|
4
|
Arndt CA and Crist WM: Common
musculoskeletal tumors of childhood and adolescence. N Engl J Med.
341:342–352. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Henderson TO, Whitton J, Stovall M,
Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP,
Meadows AT, et al: Secondary sarcomas in childhood cancer
survivors: A report from the childhood cancer survivor study. J
Natl Cancer Inst. 99:300–308. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith MA, Seibel NL, Altekruse SF, Ries
LA, Melbert DL, O'Leary M, Smith FO and Reaman GH: Outcomes for
children and adolescents with cancer: Challenges for the
twenty-first century. J Clin Oncol. 28:2625–2634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho Y, Jung GH, Chung SH, Kim JY, Choi Y
and Kim JD: Long-term survivals of stage IIb osteosarcoma: A
20-year experience in a single institution. Clin Orthop Surg.
3:48–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bielack SS, Kempf-Bielack B, Heise U,
Schwenzer D and Winkler K: Combined modality treatment for
osteosarcoma occurring as a second malignant disease. Cooperative
German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol.
17:11641999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bielack S, Beck J, Delling G, Gerein V,
Grümayer R, Hiddemann W, Jobke A, Jürgens H, Kornhuber G, Kotz R,
et al: Neoadjuvant chemotherapy of osteosarcoma. Results of the
cooperative studies COSS-80 and COSS-82 after 7 and 5 years. Klin
Padiatr. 201:275–284. 1989.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yonemoto T, Hosono A, Iwata S, Kamoda H,
Hagiwara Y, Fujiwara T, Kawai A and Ishii T: The prognosis of
osteosarcoma occurring as second malignancy of childhood cancers
may be favorable: Experience of two cancer centers in Japan. Int J
Clin Oncol. 20:613–616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pizzo PA and Poplack DG: Principles and
practice of pediatric oncology. Wolters Kluwer; Sixth edition.
2015
|
|
12
|
Meadows AT, Friedman DL, Neglia JP,
Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y and Inskip
PD: Second neoplasm in survivors of childhood cancer: Findings from
the childhood cancer survivor study cohort. J Clin Oncol.
27:2356–2362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neglia JP, Friedman DL, Yasui Y, Mertens
AC, Hammond S, Stovall M, Donaldson SS, Meadows AT and Robison LL:
Second malignant neoplasms in five-year survivors of childhood
cancer: Childhood cancer survivor study. J Natl Cancer Inst.
93:618–629. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tucker MA, D'Angio GJ, Boice JD Jr, Strong
LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, et
al: Bone sarcomas linked to radiotherapy and chemotherapy in
children. N Engl J Med. 317:588–593. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hudson MM: Late complications after
leukemia therapy. Cambridge University Press; pp. 701–713. 2012
|
|
16
|
Millard NE and De Braganca KC:
Medulloblastoma. J Child Neurol. 31:1341–1353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gajjar A, Chintagumpala M, Ashley D,
Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin
MJ, et al: Risk-adapted craniospinal radiotherapy followed by
high-dose chemotherapy and stem-cell rescue in children with newly
diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term
results from a prospective, multicentral trial. Lancet Oncol.
7:813–820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chetaille B, Massard G and Falcoz PE:
Mediastinal germ cell tumors. Anatomopathology, classification,
teratomas and malignant tumors. Rev Pneumol Clin. 66:63–70.
2010.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bokemeyer C, Nichols CR, Droz JP, Schmoll
HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, et al:
Extragonadal germ cell tumors of the mediastinum and
retroperitoneum: Results from an international analysis. J Clin
Oncol. 20:1864–1873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smoll NR and Hamilton B: Incidence and
relative survival of anaplastic astrocytomas. Neuro Oncol.
16:1400–1407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duffner PK, Horowitz ME, Krischer JP,
Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE,
Freeman CR, et al: Postoperative chemotherapy and delayed radiation
in children less than three years of age with malignant brain
tumors. N Engl J Med. 328:1725–1731. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li FP, Fraumeni JF Jr, Mulvihill JJ,
Blattner WA, Dreyfus MG, Tucker MA and Miller RW: A cancer family
syndrome in twenty-four kindreds. Cancer Res. 48:5358–5362.
1988.PubMed/NCBI
|
|
23
|
Kay RM, Eckardt JJ and Mirra JM:
Osteosarcoma and Ewing's sarcoma in a retinoblastoma patient. Clin
Orthop Relat Res. 323:284–287. 1996. View Article : Google Scholar
|
|
24
|
Andersson A, Enblad G, Tavelin B,
Björkholm M, Linderoth J, Lagerlöf I, Merup M, Sender M and Malmer
B: Family history of cancer as a risk factor for second
malignancies after Hodgkin's lymphoma. Br J Cancer. 98:1001–1005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hisada M, Garber JE, Fung CY, Fraumeni JF
Jr and Li FP: Multiple primary cancers in families with Li-Fraumeni
syndrome. J Natl Cancer Inst. 90:606–611. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhatia S and Sklar C: Second cancers in
survivors of childhood cancer. Nat Rev Cancer. 2:124–132. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Longhi A, Ferrari S, Tamburini A, Luksch
R, Fagioli F, Bacci G and Ferrari C: Late effects of chemotherapy
and radiotherapy in osteosarcoma and Ewing sarcoma patients: The
Italian Sarcoma Group Experience (1983–2006). Cancer.
118:5050–5059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hawkins MM, Wilson LM, Burton HS, Potok
MH, Winter DL, Marsden HB and Stovall MA: Radiotherapy, alkylating
agents, and risk of bone cancer after childhood cancer. J Natl
Cancer Inst. 88:270–278. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thirman MJ and Larson RA: Therapy-related
myeloid leukemia. Hematol Oncol Clin North Am. 10:293–320. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Corbett AH and Osheroff N: When good
enzymes go bad: Conversion of topoisomerase II to a cellular toxin
by antineoplastic drugs. Chem Res Toxicol. 6:585–597. 1993.
View Article : Google Scholar : PubMed/NCBI
|
